2,2,6,6-Tetramethylpiperidin-1-yloxyl-4-yl 2-acetoxybenzoate

ID: ALA4167076

Chembl Id: CHEMBL4167076

PubChem CID: 140597746

Max Phase: Preclinical

Molecular Formula: C18H24NO5

Molecular Weight: 334.39

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)Oc1ccccc1C(=O)OC1CC(C)(C)N([O])C(C)(C)C1

Standard InChI:  InChI=1S/C18H24NO5/c1-12(20)23-15-9-7-6-8-14(15)16(21)24-13-10-17(2,3)19(22)18(4,5)11-13/h6-9,13H,10-11H2,1-5H3

Standard InChI Key:  UVAYADXGIGIOCW-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4167076

    ---

Associated Targets(Human)

NCI-H1299 (3248 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

661W (31 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 334.39Molecular Weight (Monoisotopic): 334.1654AlogP: 3.14#Rotatable Bonds: 3
Polar Surface Area: 75.74Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.33CX LogD: 2.33
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.63Np Likeness Score: 0.31

References

1. Thomas K, Moody TW, Jensen RT, Tong J, Rayner CL, Barnett NL, Fairfull-Smith KE, Ridnour LA, Wink DA, Bottle SE..  (2018)  Design, synthesis and biological evaluation of hybrid nitroxide-based non-steroidal anti-inflammatory drugs.,  147  [PMID:29421569] [10.1016/j.ejmech.2018.01.077]

Source